The US inhalable drug market is anticipated to grow at a CAGR of 2.3% during the forecast period (2020-2026). The key factors driving the growth of the market include the rising prevalence of various respiratory and non- respiratory diseases in the country. The prevalence of asthma in the US is 1 in every 13 people. Over 25 million Americans are likely to have asthma, as of 2018, representing 7.7% of adults and 8.4% of children. Other factors that fuel the market growth in the country is increasing geriatric population and availability of a wide range of treatment option to choose from. Besides, a sedentary lifestyle along with unhealthy eating habits such as smoking, which is a prime factor for the increasing prevalence of several respiratory diseases such as COPD and asthma. The aforementioned factors create demand for inhalable drugs and hence drives the growth of the market in the country.
Get Free Sample link @ https://www.omrglobal.com/request-sample/us-inhalable-drugs-market
The US inhalable drug market has been segmented on the basis of the application and route of administration. Based on the application, the market is bifurcated into respiratory disease and non-respiratory diseases. The respiratory disease segment is likely to hold a significant share over the forecast period. Based on the route of administration, the market is segmented into the nasal inhalable drug and mouth inhalable drugs. The mouth segment is likely to contribute a significant share over the forecast period.
A full report of US Inhalable Drugs Market available @ https://www.omrglobal.com/industry-reports/us-inhalable-drugs-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
US Inhalable Drugs Market by Applications
- Respiratory Diseases
- Non- Respiratory Diseases
US Inhalable Drugs Market by Route of Administration
- Nasal
- Mouth
Competitive Lanscape
- AstraZeneca Plc
- AptarGroup, Inc.
- Bausch Health Companies Inc.
- Boehringer Ingelheim International GmbH
- GlaxoSmithKline Plc
- Johnson & Johnson Services Inc.
- Merck & Co., Inc.
- Pfizer Inc.
- TFF Pharmaceuticals, Inc.
The Report covers:
- Comprehensive research methodology of the US Inhalable Drugs market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the US Inhalable Drugs market.
- Insights about market determinants which are stimulating the US Inhalable Drugs market.
- Detailed and extensive market segments with regional distribution of forecast revenues.
- Extensive profiles and recent developments of the market players.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/us-inhalable-drugs-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
